Abbott Laboratories
Organization details
- Legal name
- Abbott Laboratories
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Illinois
- Headquarters city
- Abbott Park
- Headquarters state / province
- Illinois
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ABT
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0000001800
- EIN
- 36-0698440
- Wikidata ID
- Q306764
Board of directors
-
Claire Babineaux-Fontenot · DirectorSince 2023
-
Daniel J. Starks · DirectorSince 2023
-
Darren W. McDew · DirectorSince 2023
-
John G. Stratton · DirectorSince 2023
-
Kevin T. Conroy · DirectorSince 2026
-
Michael F. Roman · DirectorSince 2023
-
Michael O'Grady · DirectorSince 2023
-
Michelle Kumbier · DirectorSince 2023
-
Nancy McKinstry · DirectorSince 2023
-
Nita Ahuja · DirectorSince 2025
-
Patricia Paola Gonzalez · DirectorSince 2023
-
Robert B. Ford · Director · CHAIRMAN AND CEOSince 2023
-
Robert J. Alpern · DirectorSince 2023
-
Sally E. Blount · DirectorSince 2023
Chief executives
Director election results
Annual meeting of April 24, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.6%
-
95.0%
-
95.1%
-
97.6%
-
98.0%
-
98.7%
-
98.8%
-
99.2%
-
99.5%
-
99.5%
-
99.8%
-
99.8%
Board connections
8 of this board's directors also sit on 14 other boards. 4 are in the same sector.
-
3M Company Same sectorvia Michael F. Roman
-
AbbVie Inc. Same sectorvia Robert J. Alpern
- via Nancy McKinstry
-
Adaptive Biotechnologies Corporation Same sectorvia Kevin T. Conroy
-
Align Technology Inc. Same sectorvia Kevin T. Conroy
- via Kevin T. Conroy
- via Darren W. McDew
- via John G. Stratton
- via Nancy McKinstry
- via Michael O'Grady
- via Darren W. McDew
- via Michelle Kumbier
- via Michelle Kumbier
- via Michael F. Roman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $4,402,807
- 6 purchases by 4 insiders
- Sold, last 12 months
- $47,944,622
- 12 sales by 7 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2026 | Moreland Mary K Officer (EXECUTIVE VICE PRESIDENT) | Open-market sale | −3,500 | $116.00 | $406,000 |
| Sep 23, 2026 | Kevin T. Conroy Director | Shares withheld for tax | −52,507 | $103.99 | $5,460,203 |
| Sep 2, 2026 | MCCOY JOHN A. JR. Officer (VICE PRESIDENT AND CONTROLLER) | Open-market sale | −27 | $109.54 | $2,958 |
| Sep 1, 2026 | MCCOY JOHN A. JR. Officer (VICE PRESIDENT AND CONTROLLER) | Shares withheld for tax | −52 | $110.36 | $5,739 |
| Sep 1, 2026 | Boudreau Philip P Officer (EVP AND CFO) | Shares withheld for tax | −388 | $110.36 | $42,820 |
| Aug 25, 2026 | Robert B. Ford Director, Officer (CHAIRMAN AND CEO) | Option exercise | +151,869 | $44.40 | $6,742,984 |
| Aug 25, 2026 | Robert B. Ford Director, Officer (CHAIRMAN AND CEO) | Option exercise | +246,963 | $59.94 | $14,802,962 |
| Aug 25, 2026 | Robert B. Ford Director, Officer (CHAIRMAN AND CEO) | Open-market sale | −218,535 | $115.57 | $25,256,090 |
| Aug 25, 2026 | Robert B. Ford Director, Officer (CHAIRMAN AND CEO) | Open-market sale | −180,297 | $116.19 | $20,948,708 |
| Aug 12, 2026 | Morrone Louis H. Officer (EXECUTIVE VICE PRESIDENT) | Discretionary transaction | −12 | $107.99 | $1,296 |
| Aug 11, 2026 | Morrone Louis H. Officer (EXECUTIVE VICE PRESIDENT) | Open-market sale | −5,850 | $109.83 | $642,506 |
| Jun 30, 2026 | Morrone Louis H. Officer (EXECUTIVE VICE PRESIDENT) | Shares withheld for tax | −269 | $92.71 | $24,939 |
| Jun 27, 2026 | Cushman Elizabeth C. Officer (EVP, GC AND SECRETARY) | Shares withheld for tax | −560 | $94.12 | $52,707 |
| May 7, 2026 | John G. Stratton Director | Open-market purchase | +2,000 | $86.82 | $173,640 |
| Apr 28, 2026 | Moreland Mary K Officer (EXECUTIVE VICE PRESIDENT) | Discretionary transaction | +5,314 | $94.41 | $501,695 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Abbott Laboratories
Who is the CEO of Abbott Laboratories?
Robert B. Ford is Abbott Laboratories's CHAIRMAN AND CEO.
How many directors are on Abbott Laboratories's board?
Abbott Laboratories's board has 14 directors: Claire Babineaux-Fontenot, Daniel J. Starks, Darren W. McDew, John G. Stratton, Kevin T. Conroy, Michael F. Roman, Michael O'Grady, Michelle Kumbier, Nancy McKinstry, Nita Ahuja and 4 others.
Are Abbott Laboratories insiders buying or selling shares?
Over the last 12 months, Abbott Laboratories insiders bought $4.4 million of shares in 6 purchases and sold $47.9 million of shares in 12 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="abbott-laboratories"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.